Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy

被引:10
作者
Montero, Javier A. [1 ,2 ]
Ruiz-Moreno, Jose M. [2 ,3 ]
Fernandez-Munoz, Marta [1 ]
机构
[1] Pio del Rio Hortega Univ Hosp, Ophthalmol Unit, Valladolid 47012, Spain
[2] VISSUM, Alicante Inst Ophthalmol, Vitreoretinal Unit, Alicante, Spain
[3] Castilla La Mancha Univ, Dept Ophthalmol, Albacete, Spain
关键词
Bevacizumab; Central serous choroidopathy; Choroidal neovascularization; Photodynamic therapy; Verteporfin; PIGMENT EPITHELIAL DETACHMENT; MACULAR DEGENERATION; CHORIORETINOPATHY; VERTEPORFIN;
D O I
10.5301/EJO.2011.6290
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To report the anatomic and functional outcome of intravitreal bevacizumab (IVB) to treat choroidal neovascularization (CAM following photodynamic therapy (POT) to treat recurrent central serous choroidopathy (CSC). METHODS. This was an interventional case report in which verteporfin PDT was performed in a case of recurrent CSC. RESULTS. Following PDT, the patient developed juxtafoveal CNV that was later treated by IVB, achieving CNV closure and recovery of visual acuity. CONCLUSIONS. Photodynamic therapy is a useful therapy to treat recurrent CSC, though it may be associated with potentially severe complications such as CNV. Intravitreal bevacizumab seems a good alternative treatment in the management of this condition.
引用
收藏
页码:503 / 505
页数:3
相关论文
共 10 条
[1]   Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy - One-year results of a randomized controlled trial [J].
Chan, Wai-Man ;
Lai, Timothy Y. Y. ;
Lai, Ricky Y. K. ;
Liu, David T. L. ;
Lam, Dennis S. C. .
OPHTHALMOLOGY, 2008, 115 (10) :1756-1765
[2]   Photodynamic therapy induces selective extravasation of macromolecules: Insights using intravital microscopy [J].
Debefve, E. ;
Cheng, C. ;
Schaefer, S. C. ;
Yan, H. ;
Ballini, J. -P. ;
van den Bergh, H. ;
Lehr, H. -A. ;
Ruffieux, C. ;
Ris, H. -B. ;
Krueger, T. .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2010, 98 (01) :69-76
[3]   Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy [J].
Hayashi, Kengo ;
Ohno-Matsui, Kyoko ;
Shimada, Noriaki ;
Moriyama, Muka ;
Hara, Wakako ;
Yoshida, Takeshi ;
Tokoro, Takashi ;
Mochizuki, Manabu .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (05) :609-618
[4]   Retinal Pigment Epithelial Tear After Half Fluence PDT for Serous Pigment Epithelial Detachment in Central Serous Chorioretinopathy [J].
Kim, Seong-Woo ;
Oh, Jaeryung ;
Oh, In Kyung ;
Huh, Kuhl .
OPHTHALMIC SURGERY LASERS & IMAGING, 2009, 40 (03) :300-303
[5]   Severe choroidal ischemia following Photodynamic Therapy for pigment epithelial detachment and chronic central serous chorioretinopathy [J].
Lee, Phil Young ;
Kim, Ki Seok ;
Lee, Won Ki .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (01) :52-56
[6]   Bevacizumab vs Photodynamic Therapy for Choroidal Neovascularization in Multifocal Choroiditis [J].
Parodi, Maurizio Battaglia ;
Iacono, Pierluigi ;
Kontadakis, Dimitrios Stelyos ;
Zucchiatti, Ilaria ;
Cascavilla, Maria Lucia ;
Bandello, Francesco .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (09) :1100-1103
[7]   Photodynamic therapy for chronic central serous chorioretinopathy [J].
Ruiz-Moreno, Jose M. ;
Lugo, Francisco L. ;
Armada, Felix ;
Silva, Rufino ;
Montero, Javier A. ;
Fernando Arevalo, J. ;
Arias, Luis ;
Gomez-Ulla, Francisco .
ACTA OPHTHALMOLOGICA, 2010, 88 (03) :371-376
[8]  
Schmidt-Erfurth U, 1999, ARCH OPHTHALMOL-CHIC, V117, P1177
[9]   Influence of vertepon photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration [J].
Tatar, Olcay ;
Adam, Annemarie ;
Shinoda, Kei ;
Yoeruek, Efdal ;
Szurman, Peter ;
Bopp, Silvia ;
Eckardt, Claus ;
Bartz-Schmidt, Karl Ulrich ;
Grisanti, Salvatore .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (06) :713-723
[10]  
YAMAN A, 2007, B SOC BELGE OPHTALMO, V303, P69